Scott Munzer

Scott Munzer has extensive work experience in the biotechnology and pharmaceutical industry. Scott is currently employed at BlueRock Therapeutics as the Senior Director of Editing Reagents & Analytics. Prior to that, they worked at Casebia Therapeutics as the Associate Director of Process Sciences, where they built and led a team responsible for developing and improving CRISPR gene editing reagents.

Before joining Casebia Therapeutics, Munzer held various roles at Genocea Biosciences. Scott served as the Associate Director of Process Sciences, leading purification optimization studies and overseeing testing of cell and virus banks. Scott also worked as a Group Leader of Protein Biochemistry, where they engineered vaccine antigens and managed production and purification activities. Additionally, they worked as a Senior Program Manager, guiding process development for a genital herpes vaccine.

Earlier in their career, Munzer worked at Alseres Pharmaceuticals as the Director of Program Operations. In this role, they provided scientific oversight and was involved in tech transfer of manufacturing and analytical processes for protein biologics products. Scott also worked at BioAxone Therapeutic as the Associate Director of Protein Engineering, where they led the development and production of novel protein therapeutic drugs.

Munzer began their career as a Research Associate at Converzyme and later worked as a Postdoctoral Fellow at the Protein Engineering Network of Centres of Excellence and the Clinical Research Institute of Montreal.

Overall, Munzer has built a strong expertise in process development, protein engineering, and project management within the biotechnology and pharmaceutical industry.

Scott Munzer obtained a Ph.D. in Experimental Medicine/Biochemistry from McGill University. Prior to that, they received a B.A. in Zoology from the University of Vermont.